Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C](R)-PK11195 positron emission tomography study

Turner, M.R, Cagnin, A, Turkheimer, F.E, Miller, C.C.J, Shaw, C.E, Brooks, D.J, Leigh, P.N, Banati, R.B·2004·Neurobiology of Disease
DOI 10.1016/j.nbd.2003.12.012

Cited by (737)

Items 601–700 of 737

  1. PET Imaging in ALS
    Bart Swinnen, Koen Van Laere, Philip Van Damme · 2016 · InTech eBooks
  2. Amyotrophic Lateral Sclerosis
    Rita Sattler, Jeffrey D. Rothstein · 2012 · Oxford University Press eBooks
  3. Theme 7 Pre-clinical therapeutic strategies
    Vittoria Lombardi, Daniele Carassiti, Gavin Giovannoni, Ching‐Hua Lu, Rocco Adiutori, Andrea Malaspina · 2019 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  4. Basic Concepts and Emergent Disease Mechanisms of Amyotrophic Lateral Sclerosis
    Oleksandra Sirozh, Anabel Sáez-Mas, Vanesa Lafarga, Óscar Fernández-Capetillo · 2022 · Elsevier eBooks
  5. Variability of the Penn upper motor neuron score in amyotrophic lateral sclerosis: need for a revised score
    Anna Bystrup Jacobsen, Gaia Fanella, Mamede A. de Carvalho, Martin Koltzenburg, Miguel Oliveira Santos, Bülent Çengiz, Jakob Udby Blicher, Izabella Obál, Mia B. Heintzelmann, Wilfred A. Nix et al. · 2025 · Journal of Neurology
  6. Correlation analysis between excitability in the somatosensory cortex and structural changes in amyotrophic lateral sclerosis
    Ayşegül Gündüz, Tuba Akıncı, Osman Aykan Kargın, Melih Tütüncü, Serdar Arslan, Nurten Uzun · 2025 · Clinical Neurophysiology Practice
  7. Clinical Utility of Far‐Field Potentials in Amyotrophic Lateral Sclerosis
    Aicee Dawn Calma, Nathan Pavey, Cláudia Santos Silva, Yukiko Tsuji, Mehdi A. J. van den Bos, Michelle Anne Farrar, Parvathi Menon, Steve Vucic · 2025 · Muscle & Nerve
  8. Inflammation in Neuronal Intranuclear Inclusion Disease (NIID): mechanisms, biomarkers, and therapeutic implications
    Xiaoxiao Zheng, Ling Li, Hongyue Ma, Xiuli Li, Xinhong Feng · 2025 · Journal of Neuroinflammation
  9. Repurposing immunomodulatory drugs targeting microglia for amyotrophic lateral sclerosis
    Kirsten Johanna Hendricus Maes, Jacob J. Briedé · 2025 · Brain Research
  10. Non-cell autonomous autophagy in amyotrophic lateral sclerosis: A new promising target?
    Francesca Rosso, Rocio Magdalena, Carola Torazza, Francesca Bacchetti, Marco Milanese, Angelo Poletti, Giambattista Bonanno, Riccardo Cristofani, Tiziana Bonifacino · 2025 · Neurobiology of Disease
  11. C9orf72 in myeloid cells prevents an inflammatory response to microbial glycogen
    Blake T. McCourt, Katelyn Lemr, Shinjon Chakrabarti, Elizabeth Woidke, Sara Ramaiah, Vaidhvi Singh, Naseer Sangwan, J. Mark Brown, Fabio Cominelli, Alexander Rodriguez‐Palacios et al. · 2026 · Cell Reports
  12. TDP-43 pathology triggers neuroinflammation and cognitive impairment by inducing microglial necroptosis
    Shenrui Guo, Hongfu Jin, Hui Sun, Shuo Huang, Yuanyuan Chen, Yuge Chang, Yu Zhang, Lin Ding, Suyun Chen, Chenglai Fu et al. · 2026 · EMBO Molecular Medicine
  13. Multimodal strategies for diagnosis, stratification, and therapeutic monitoring in ALS
    Rafael López‐Blanch, María Oriol‐Caballo, José M. Estrela, Elena Obrador · 2026 · Neuroscience & Biobehavioral Reviews
  14. Immunology and microbiome: Implications for motor systems
    Yasamin Mahjoub, Davide Martino · 2023 · Handbook of clinical neurology
  15. PET Imaging of Translocator Protein Expression in Neurological Disorders
    David James Brooks · 2014 · Springer eBooks
  16. Nouveaux marqueurs biologiques et radiologiques de la sclérose latérale amyotrophique
    Pierre‐François Pradat · 2009 · La Presse Médicale
  17. Clinical contribution of PET neurotransmission imaging in neurological disorders.
    Gaëtan Garraux, Éric Salmon · 2005 · PubMed
  18. Lower motor neurons – Counting cogs in the ALS machine
    Neil G. Simon · 2016 · Clinical Neurophysiology
  19. Molecular and Cellular Insights: Neuroinflammation and Amyotrophic Lateral Sclerosis
    Arun Upadhyay, Ayeman Amanullah, Vibhuti Joshi, Ribhav Mishra, Amit Mishra · 2016 · Springer eBooks
  20. Corticomotor Excitability in Two Kinds of Motor Neuron Diseases: A Study on the Patients With Amyotrophic Lateral Sclerosis and Poliomyelitis Survivors
    Nermi̇n Görkem Şi̇ri̇n, Bahar Erbaş, Emel Oğuz Akarsu, Gülşah Gula, Elif Kocasoy‐Orhan, Hava Özlem Dede, Mehmet Barış Baslo, Halil Atilla Idrısoğlu, Ayşegül Ketenci, Ali Emre Öge · 2020 · Journal of Clinical Neurophysiology
  21. Neuroinflammation in Neurological Disorders
    Jun‐ichi Kira · 2013 · Advances in neurobiology
  22. Excitotoxicity
    Claire Henchcliffe, M. Flint Beal · 2007 · Handbook of clinical neurology
  23. Neuroinflammation in Neurological Dysfunction and Degeneration
    Shih‐Heng Chen, Esteban A. Oyarzabal, Janine Hertzog Santos, Qingshan Wang, Lulu Jiang, Jau‐Shyong Hong · 2015 · Elsevier eBooks
  24. Motoneuron Disease: Clinical
    Hristelina S. Ilieva, Nicholas John Maragakis · 2017 · Advances in neurobiology
  25. Amyotrophic Lateral Sclerosis
    Martin R. Turner, Marco Pagani · 2020 · Springer eBooks
  26. Neuroimmunology of Amyotrophic Lateral Sclerosis
    J. Henkel-Tigges, David R. Beers, Weihua Zhao, Stanley H. Appel · 2014
  27. Evidence for a Growing Involvement of Glia in Amyotrophic Lateral Sclerosis
    Rowan A. W. Radford, Andrés Vidal-Itriago, Natalie M. Scherer, Albert Lee, Manuel B. Graeber, Roger S. Chung, Marco Morsch · 2021 · Wiley eBooks
  28. Future Advances in Early Phase Clinical Development for Disease Modifying Therapies for Neurodegenerative Diseases
    Philip H.C. Kremer, Geert Jan Groeneveld · 2022 · Medical Research Archives
  29. Immunotherapy for Neurodegenerative Movement Disorders
    Rodney Lee Mosley, Maamoon Saleh, Katherine E. Olson · 2024 · Springer eBooks
  30. Integration of Serum Neurofilament Light Chain and Cortical Dysfunction Improves Diagnostic Accuracy in ALS
    Aicee Dawn Calma, Nathan Pavey, Yukiko Tsuji, Amirul Ab Ghapar, Mehdi A. J. van den Bos, Bronwen Orden, Grace Lee, Linda Mekhael, Julie Ryder, C A Silva et al. · 2026 · Annals of Clinical and Translational Neurology
  31. MODULATION OF THE ALPHA-7 NICOTINIC ACETYLCHOLINE RECEPTOR FOLLOWING EXPERIMENTAL RAT BRAIN INJURY IMPROVES CELLULAR AND BEHAVIORAL OUTCOMES
    Thomas Woodcock · 2010 · UKnowledge (University of Kentucky)
  32. Motor neuron disease with malignancy: Clinical and pathophysiological insights
    Mana Higashihara, Parvathi Menon, Nimeshan Geevasinga, Mehdi A. J. van den Bos, Matthew C. Kiernan, Steve Vucic · 2019 · Clinical Neurophysiology
  33. Oxidoreductase
    Mahmoud Ahmed Mansour · 2020 · IntechOpen eBooks
  34. Immunomodulatory treatment for amyotrophic lateral sclerosis/motor neuron disease
    Hardeep Singh Malhotra, Balendra Pratap Singh, Neeraj Kumar, Ravindra Kumar Garg, Richard Kirubakaran, Hedley C A Emsley, Suresh Kumar Chhetri, Caroline A. Mulvaney, Gemma Villanueva · 2022 · Cochrane Database of Systematic Reviews
  35. Amyotrophic Lateral Sclerosis: Neurochemical Biomarkers
    Federico Verde, Nicola Ticozzi · 2022 · Springer eBooks
  36. The Therapeutic Potential and Molecular Mechanisms Underlying the Neuroprotective Effects of Sativex® - A Cannabis-derived Spray
    Sina Motamedy, Bahareh Soltani, Halimeh Kameshki, Asmae Alipour Kermani, Reza Saboori Amleshi, Masoud Nazeri, Mohammad Shabani · 2024 · Mini-Reviews in Medicinal Chemistry
  37. Amyotrophic Lateral Sclerosis: A Glial Perspective
    Chiara F. Valori, Liliana Brambilla, Daniela Rossi · 2014 · Springer eBooks
  38. PET Imaging of Microglia Activation in Neuropsychiatric Disorders with Potential Infectious Origin
    Hans Christiaan Klein, Lot D. de Witte, Robert C. Bransfield, Peter Paul De Deyn · 2014 · Springer eBooks
  39. In Vivo Imaging in Neurodegenerative Diseases
    Xueying Wang, Michal Arbel‐Ornath, Susanne Wegmann, Ksenia V. Kastanenka, Brian J. Bacskai · 2014 · Springer eBooks
  40. Motor Neuron Disease: Amyotrophic Lateral Sclerosis
    Nicholas John Maragakis, Jeffrey D. Rothstein · 2007 · Elsevier eBooks
  41. Microglial Biology and Physiology
    Oleg Butovsky, Charlotte Madore, Howard L. Weiner · 2016 · Springer eBooks
  42. Signs of MRI affection of brain in сlassical Amyotrophic Lateral Sclerosis patients
    Стучевская Тима Романовна, Д И Руденко, Valery M Kazakov, O. F. Pozdnyakova, Поздняков Александр Владимирович, Alexandr A. Skoromets, L. A. Tyutin · 2016 · Pediatrician (St Petersburg)
  43. Amyotrophic Lateral Sclerosis and Other TDP-43 Proteinopathies
    Jorge Gómez-Deza, Christopher E. Shaw · 2018 · Elsevier eBooks
  44. PET Imaging of Microglia Activation and Infection in Neuropsychiatric Disorders with Potential Infectious Origin
    Hans Christiaan Klein, Lot D. de Witte, Robert C. Bransfield, Peter Paul De Deyn · 2020 · Springer eBooks
  45. Seismic Vulnerability Assessment Of Bridges Using Fragility-Based Approach
    Manish Kumar Nimoriya Ritu Tomar · 2016 · INFM-OAR (INFN Catania)
  46. Neuroimaging in multiple system atrophy
    Giacomo Tondo, Cristoforo Comi, Andrea Naldi, Edoardo Rosario de Natale, Marios Politis · 2022 · Elsevier eBooks
  47. Evaluation of reference tissue models for analysing [11C](R)-PK11195 studies
    Marc A Kropholler, Bart N.M. van Berckel, Alie Schuitemaker, Hedy Folkersma, Gert Luurtsema, Albert D. Windhorst, Ronald Boellaard, Adriaan A. Lammertsma · 2005 · Journal of Cerebral Blood Flow & Metabolism
  48. Superoxide dismutase 1 and amyotrophic lateral sclerosis
    Pär Jonsson · 2005 · KTH Publication Database DiVA (KTH Royal Institute of Technology)
  49. Editorial on the original article entitled "Genetic validation of a therapeutic target in a mouse model of ALS" published in the Science Translational Medicine on August 6, 2014.
    Vincenzo Silani · 2015 · PubMed
  50. Effekte der präsymptomatischen Applikation der Rho-Kinase-Inhibitoren Fasudil und Y-27632 im SOD1-(G93A)-Mausmodell der Amyotrophen Lateralsklerose
    Suhr, Martin Erwin Hermann · 2017
  51. Commentary: Calcium in the pathomechanism of amyotrophic lateral sclerosis - Taking center stage?
    László Siklós · 2017 · Journal of Neurology and Neuromedicine
  52. Amyotrophic Lateral Sclerosis
    Martin R. Turner · 2014 · Springer eBooks
  53. Biomarkers in Disease Diagnosis and Treatment
    Ralf Hoffmann · 2006 · Kluwer Academic Publishers eBooks
  54. Neuroimaging in the Management of Motor Neuron Diseases
    Massimo Filippi, Federica Agosta, Sharon Abrahams, Franz Fazekas, Julian Großkreutz, Sanjay Kalra, Jan Kassubek, Vincenzo Silani, Martin R. Turner, Joseph C. Masdeu · 2011
  55. Understanding the gender-based mechanism of MSO treatment in ALS mice: A metabolic characterization of the SOD1-G93A mouse model
    Monica Bame · 2012
  56. Caracterização celular e molecular da influência do astrócito na degeneração do neurônio motor no modelo in vitro da esclerose lateral amiotrófica utilizando camundongos trangênicos para SOD1 humana mutante
    Juliana Milani Scorisa · 2013 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  57. PET and SPECT in the Evaluation of Patients with Central Motor Disorders
    John Peter Seibyl · 2009 · Springer eBooks
  58. Identifying, Targeting, and Exploiting a Common Misfolded, Toxic Conformation of SOD1 in ALS: A Dissertation
    Rotunno, Melissa S. · 2015 · eScholarship@UMassChan
  59. Die Bedeutung von CCAAT/Enhancer Binding Protein (C/EBP) beta und Suppressor of Cytokine Signalling (SOCS) 1 & 3 für die Pathogenese der Amyotrophen Lateralsklerose (ALS)
    Steffen Franz · 2007 · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München)
  60. Investigation of the Effects of Image Signal-to-Noise Ratio on TSPO PET Quantification of Neuroinflammation
    Christopher Constable · 2013 · The Sydney eScholarship Repository (The University of Sydney)
  61. Microglia in pathogenesis of amyotrophic lateral sclerosis
    Yin Fan, Xueqi Wang · 2009 · Academic Journal of Second Military Medical University
  62. Degenerative processes in organotypic spinal slices: challenging pre-motor network with stress conditions
    Manuela Medelin · 2014 · OpenstarTs (Univeristy of Trieste https://www.units.it/)
  63. Human Subject with Unexpected Biodistribution of [11C]PK11195
    Anne Roivainen · 2011 · The Open Nuclear Medicine Journal
  64. Traces of disease in amyotrophic lateral sclerosis
    Esther Verstraete · 2012 · Utrecht University Repository (Utrecht University)
  65. Análise da influência da microglia mutante na sobrevida do neurônio motor no modelo in vitro da esclerose lateral amiotrófica utilizando camundongos transgênicos para SOD1 humana
    Tatiana Duobles · 2013 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  66. Role for the Peripheral Benzodiazepine Receptor in Neuroinflammation of Neurodegenerative disorders
    Sriram Venneti · 2006 · D-Scholarship@Pitt (University of Pittsburgh)
  67. The role of the corticomotorneurons in pathogenesis of amyotrophic lateral sclerosis
    Parvathi Menon · 2014 · The Sydney eScholarship Repository (The University of Sydney)
  68. Análise da participação das células neuronais e não-neuronais na Esclerose Lateral Amiotrófica em camundongos transgênicos para SOD1 humana utilizando técnicas de microdissecção a laser e PCR em tempo real
    G. P. de Oliveira · 2014 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  69. Regulation of neural progenitor cell proliferation and fate by proteolytic pathways and inflammatory signals in the brain
    Raili Koivuniemi · 2013 · Työväentutkimus Vuosikirja
  70. PET Imaging in Neuroinflammation
    David James Brooks · 2014 · Springer eBooks
  71. ORIGINAL RESEARCH The Topography of Brain Microstructural Damage in Amyotrophic Lateral Sclerosis Assessed Using Diffusion Tensor MR Imaging
    Elisa Canu, Federica Agosta, Nilo Riva, Stefania Sala, Alessandro Cesare Prelle, Domenico Caputo, Michele Perini, Giacomo P. Comi, Massimo Filippi · 2011
  72. Glia-Motoneuron dialogue in ALS onset and progression in SOD1G93A-mice model
    Catarina de Pais Paiva Santos · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  73. 3-isoquinolinecarboxamide in humans; an imaging agent for in vivo assessment of peripheral benzodiazepine receptor activity with positron emission tomography
    Anne Roivainen, Kjell Någren, Jussi Hirvonen, Vesa Oikonen, Pauliina Virsu, Tuula Tolvanen, Juha O. Rinne · 2009
  74. L’utilisation de biomarqueurs dans la SLA est-elle d’actualité ?
    Hélène Blasco, Philippe Corcia, Pierre‐François Pradat · 2014 · La Presse Médicale
  75. Neuroinflammatory processes in the amyotrophic latera sclerosis brain : study of hSOD1 G93A rat model
    Danijela Bataveljić · 2012
  76. The role of humoral immune response in the aetiopathogenesis of amyotrophic lateral sclerosis
    Milena M. Milosevic · 2012
  77. This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Biomarkers in Amyotrophic Lateral Sclerosis Facts and Future Horizons
    Pierre‐François Pradat, Michel Dib · 2009
  78. Neuroimaging in Amyotrophic Lateral Sclerosis
    Angelina Cistaro · 2016 · Springer eBooks
  79. Neuroinflammation in Huntington’s & Related Neurodegenerative Disorders
    Vivek Kumar Tripathi, Nihar Ranjan Jana · 2016 · Springer eBooks
  80. Neural Substrates of Parkinson's Disease
    Yuko Koshimori · 2016 · TSpace (University of Toronto)
  81. Effect of elevated calcium level and calcium binding proteins in acute and chronic degeneration of motor neurons
    Roland Patai · 2017 · SZTE Repository of Dissertations (University of Szeged)
  82. Exploring deregulated signals involved in motor neuron-microglia cross-talk in ALS
    Maria Inês Cunha · 2014 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  83. Characterizing Cerebral Degeneration in Amyotrophic Lateral Sclerosis with Texture Analysis
    Abdullah H. Ishaque · 2020 · ERA: Education and Research Archive (University of Alberta)
  84. Amiotrophic Lateral Sclerosis
    Andrew D. Schweitzer, Apostolos John Tsiouris · 2021 · Springer eBooks
  85. Introduction to Molecular Neuroimaging Applications
    Elizabeth Tong, Ghiam Yamin · 2021 · Springer eBooks
  86. PET Imaging of Autoimmune Diseases and Inflammatory Bowel Diseases
    Alberto Signore, Onofrio A. Catalano, Shadi Abdar Esfahani, Chiara Lauri · 2022 · Elsevier eBooks
  87. Inflammasome mediated neuronal-microglial crosstalk: a therapeutic substrate for the familial C9orf72 variant of the frontotemporal dementia/amyotrophic lateral sclerosis
    Kyle J. Trageser, Chad Smith, Eun‐Jeong Yang, Ruth Iban‐Arias, Tatsunori Oguchi, Maria Sebastian-Valverde, Umar Haris Iqbal, Henry D. Wu, Molly S. Estill, Md Al Rahim et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  88. Plasma miRNA-214 is a predictive candidate biomarker of progression speed in patients with ALS
    Min‐Young Noh, Min‐Soo Kwon, Ki‐Wook Oh, Minyeop Nahm, Jinseok Park, Young-Eun Kim, Hee Kyung Jin, Jae‐sung Bae, Chang‐Seok Ki, Seung Hyun Kim · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  89. THEME 1 IMPROVING DIAGNOSIS, PROGNOSIS AND DISEASE PROGRESSION
    2014 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  90. Faculty Opinions recommendation of The methodology of TSPO imaging with positron emission tomography.
    Daniela Perani · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  91. Sensory involvement in amyotrophic lateral sclerosis
    1987 · Electroencephalography and Clinical Neurophysiology
  92. Utility of the ALSFRS‐R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank
    Leigh E. Colvin, Zachariah W. Foster, Thor D. Stein, Manisha Thakore‐James, Mohammad Kian Salajegheh, Kendall Carr, Keith R. Spencer, Nazifa Abdul Rauf, Latease Adams, James G. Averill et al. · 2022 · Muscle & Nerve
  93. Brain Derived Neurotrophic Factor (BDNF) as a Mediator of Microglia-Induced Neuroinflammation
    Tryston Charlton · 2022 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  94. Retinal Disorders in Humans and Experimental ALS Models
    Pilar Rojas, Ana Isabel Ramirez, Rosa de Hoz, Manuel Cadena, Elena Salobrar‐García, Inés López‐Cuenca, José A. Fernández‐Albarral, Lídia Sánchez-Puebla, José A. Matamoros, Juan Jose Salazar et al. · 2022 · IntechOpen eBooks
  95. Amyotrophic Lateral Sclerosis Involving Gliopathy
    Asmaa Haj-Khlifa, Hafida El Ghachi, Mjid Oukhrib, Halima Gamrani, Moulay Mustapha Bouyatas · 2023 · Advances in bioinformatics and biomedical engineering book series
  96. Oxisteróis e sua relação com a neuroinflamação na esclerose lateral amiotrófica
    Rodrigo Santiago Lima · 2023 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  97. Análise eletrofisiológica em doentes com esclerose lateral amiotrófica que receberam duas infusões de células-tronco mesenquimais no líquor
    Alberto Andrade de Mello · 2024
  98. Selective muscle involvement in amyotrophic lateral sclerosis: Evidence inferred from the point of motor unit firing rates
    Sezin Alpaydın Baslo, Nermi̇n Görkem Şi̇ri̇n, Elif Kocasoy Orhan, Mehmet Barış Baslo, Ali Emre Öge · 2024 · Nöro Psikiyatri Arşivi
  99. Human amyotrophic lateral sclerosis/motor neuron disease: The disease-associated microglial pathway is upregulated and APOE ε2 is protective
    Bridget Ashford, Julie E. Simpson, Charlotte Dawson, Delphine Boche, Johnathan Cooper‐Knock, Paul Roy Heath, Daniel J. Fillingham, Charlie Appleby‐Mallinder, Wenbin Wei, Mark Dunning et al. · 2025 · medRxiv
  100. Oxysterol Alterations in SOD1G93A ALS Rats: 25-Hydroxycholesterol and LPS-Binding Protein in Disease Progression
    Rodrigo Santiago Lima, Rosangela S. Santos, Adriano B. Chaves‐Filho, Isis Ferraz Libório Trzan, Alex Inague, Rodrigo Lucas de Faria, Lucas S. Dantas, Isabella Fernanda Dantas Pinto, Marisa Helena Gennari de Medeiros, Alexandre A. Steiner et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)